James M. Osher

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 138 citations · Full text

Medicine, Ophthalmology, Surgery +9

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana et al. · The Lancet · 2024 · 113 citations

Health Professions, Ophthalmology, Pharmacotherapy +10

Fate of anterior capsule tears during cataract surgery

Frederico França Marques, Daniela M.V. Marques, Robert H. Osher et al. · Journal of Cataract & Refractive Surgery · 2006 · 92 citations

Medicine, Ophthalmology, Surgery +17

Intravitreal methotrexate infusion for proliferative vitreoretinopathy

Ama Sadaka, Robert A. Sisk, James M. Osher et al. · Clinical ophthalmology · 2016 · 88 citations · Full text

Medicine, Ophthalmology, Surgery +11

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

Masahiko Shimura, Shigehiko Kitano, Nahoko Ogata et al. · Japanese Journal of Ophthalmology · 2023 · 21 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +9